1[1]Castagnetta L, Traina A, Agostara B, et al. Ligand binding and cytochemical analysis of estrogen and progesterone receptors in relation to follow-up in patients with breast cancer[J]. Ann N Y Acad Sci,2002, 963: 98-103.
2[2]Costa SD, Lange S, Klinga K, et al. Factors influencing the prognostic role of estrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up[J]. EurJ Cancer, 2002, 38(10): 1329-34.
3[3]Jakic-Razumovic J, Blazicevic V, Uzarevic B, et al. Prognostic significance of newly formed blood vessels in the tumors of patients with breast cancer[J]. Lijec Vjesn, 2002, 124(5): 123-8.
4[4]Nichols DW, WolffDJ, Self S, et al. A testing algorithm for determination of HER2 status in patients with breast cancer[J]. Ann Clin Lab Sci, 2002, 32(1): 3-11.
5[5]Nunes RA, Harris LN. The HER2 Extracellular domain as a prognostic and predictive factor in breast cancer[J]. Clin Breast Cancer, 2002,3(2): 125-35.
6[8]Goldhirsch A, Gelber RD. Endocrine the rapies of breast cancer[J].Semin Oncol, 1996, 23: 494-505.
7[9]Kolar Z, Murray PG, Zapletalova J. Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression[J]. Neoplasma, 2002, 49(2): 110-3.
1Alderliesten T, den Hollander S, Yang TJ, et al. Dosimetric impact of post-operative seroma reduction during radiother- apy after breast-conserving surgery [ J ]. Radiother Oncol, 2011,100(2) :265.
2Petersen RP, Truong PT, Kader HA, et al. Target volume delineation for partial breast radiotherapy planning:clinical characteristics associated with low interobserver concord- ance[ J]. Int J Radiat Oncol Biol Phys,2007,69( 1 ) :41.
3Kader HA,Truong PT,Pai R,et al. When is CT-based postop- erative seroma most useful to plan partial breast radiotherapy: evaluation of clinical factors affecting seroma volume and clar- ity[J]. Int J Radiat Oncol Biol Phys,2008,72(4):1064.
4Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: lO-year re- sults of the randomized boost versus no boost EORTC 22881-10882 trial[ J]. J Clin Onco1,2007,25 ( 22 ) :3259.
5Chung M J, Suh Y J, Lee HC, et al. Tumor bed volumetric changes during breast irradiation for the patients with breast cancer[J]. Radiat Oncol J,2013,31 (4) :228.
6Cho H, Kim C. Volumetric changes in the lumpectomy cavi- ty during whole breast irradiation after breast conserving surgery[J]. Radiat Oneol J,2011,29(4) :277.
